Almatica Company Profile

✉ Email this page to a colleague

ALMATICA has nine approved drugs.

There are three US patents protecting ALMATICA drugs.

There are fifty-three patent family members on ALMATICA drugs in thirty-one countries and eighteen supplementary protection certificates in nine countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Almatica	SERTRALINE HYDROCHLORIDE	sertraline hydrochloride	CAPSULE;ORAL	215133-001	Oct 4, 2021		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Almatica	SERTRALINE HYDROCHLORIDE	sertraline hydrochloride	CAPSULE;ORAL	215133-002	Oct 4, 2021		RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-004	Apr 18, 2023		RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Almatica	ZOLPIDEM TARTRATE	zolpidem tartrate	CAPSULE;ORAL	215721-001	May 9, 2023		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Almatica	MACRODANTIN	nitrofurantoin, macrocrystalline	CAPSULE;ORAL	016620-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Almatica	ZESTORETIC	hydrochlorothiazide; lisinopril	TABLET;ORAL	019888-002	Jul 20, 1989	4,472,380	⤷ Sign Up
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-001	Jan 28, 2011	6,635,280	⤷ Sign Up
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-002	Jan 28, 2011	6,340,475	⤷ Sign Up
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-002	Jan 28, 2011	8,333,992	⤷ Sign Up
Almatica	ZESTORETIC	hydrochlorothiazide; lisinopril	TABLET;ORAL	019888-003	Nov 18, 1993	4,374,829*PED	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	300 mg and 600 mg	➤ Subscribe	2011-10-31

Patent Number	Expiration Date
⤷ Sign Up	⤷ Sign Up

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0480717	98C0025	Belgium	⤷ Sign Up	PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
0565634	06C0030	France	⤷ Sign Up	PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
0347066	2002C/039	Belgium	⤷ Sign Up	PRODUCT NAME: ESCITALOPRAM. OXALAT. (INN) ESCITALOPRAM; NATL. REGISTRATION NO/DATE: 7004 IE10 F 3 20020729; FIRST REGISTRATION: SE 17084 20011207
2236132	122015000006	Germany	⤷ Sign Up	PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
0454511	SPC/GB99/008	United Kingdom	⤷ Sign Up	PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.